FLUGEN INC - THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO IDENTIFY HUMORAL CORRELATES OF PROTECTION FOLLOWING H3N2 M2SR VACCINATION, SUPPORTING THE CLINICAL DEVELOPMENT OF M2SR AS A STRATEGY TO INDUCE BOTH SEASONAL INFLUENZA IMMUNITY AND PRE-PANDEMIC PROTECTION A

PIID: 75A50125C00005

Signed Date: Feb 2, 2026Effective Date: Jul 25, 2025End Date: Closes in 123 days

Award $

$742K

Vendor

FLUGEN INC

NAICS

541714

Signed Date

Feb 2, 2026

Key Details

Dollars Obligated

$741,722.15

Base & All Options

Awarding Agency

Department of Health and Human Services

Awarding Sub-Agency

Office of Assistant Secretary for Preparedness and Response

NAICS Code

541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)

Product Service Code

AN12 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH

Extent Competed

FULL AND OPEN COMPETITION

Number of Offers

Place of Performance

MADISON, WI, 537111084, CD-WI-02

Description

THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO IDENTIFY HUMORAL CORRELATES OF PROTECTION FOLLOWING H3N2 M2SR VACCINATION, SUPPORTING THE CLINICAL DEVELOPMENT OF M2SR AS A STRATEGY TO INDUCE BOTH SEASONAL INFLUENZA IMMUNITY AND PRE-PANDEMIC PROTECTION A

Context & Analysis

On Feb 2, 2026, Department of Health and Human Services obligated $741,722.15 to FLUGEN INC for the overall objective of this contract is to identify humoral correlates of protection following h3n2 m2sr vaccination, supporting the clinical development of m2sr as a strategy to induce both seasona…. The award is classified under NAICS 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) and issued as a firm fixed price contract. Competition extent: full and open competition with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in MADISON, WI. The contract is scheduled through Feb 28, 2027 — approximately 4 months remaining.